81 related articles for article (PubMed ID: 18038462)
21. Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls.
Liu H; Huang J; Dou M; Liu Y; Xiao B; Liu X; Huang Z
Sci Rep; 2017 Apr; 7(1):1207. PubMed ID: 28446795
[TBL] [Abstract][Full Text] [Related]
22. [Haplotypes in the IL2RA region associated with diabetes and expression of the IL2RA protein on lymphocytes populations].
Plagnol V
Med Sci (Paris); 2010 Mar; 26(3):236-8. PubMed ID: 20346270
[No Abstract] [Full Text] [Related]
23. Variation in the Epstein-Barr virus receptor, CR2, and risk of multiple sclerosis.
Simon K; Yang X; Munger K; Ascherio A
Mult Scler; 2007 Aug; 13(7):947-8. PubMed ID: 17881405
[No Abstract] [Full Text] [Related]
24. Universal false discovery rate estimation methodology for genome-wide association studies.
Forner K; Lamarine M; Guedj M; Dauvillier J; Wojcik J
Hum Hered; 2008; 65(4):183-94. PubMed ID: 18073488
[TBL] [Abstract][Full Text] [Related]
25. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
Faller E; Kakal J; Kumar R; Macpherson P
Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis.
Mamutse G; Woolmore J; Pye E; Partridge J; Boggild M; Young C; Fryer A; Hoban PR; Rukin N; Alldersea J; Strange RC; Hawkins CP
Mult Scler; 2008 Nov; 14(9):1280-3. PubMed ID: 18653739
[TBL] [Abstract][Full Text] [Related]
27. Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families.
Ramagopalan SV; Morrison KM; Para A; Handel A; Disanto G; Handunnetthi L; Orton SM; Sadovnick AD; Ebers GC
J Neuroimmunol; 2009 Jul; 212(1-2):142-4. PubMed ID: 19428123
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
[TBL] [Abstract][Full Text] [Related]
29. Linkage disequilibrium analyses within chromosome 19p in multiple sclerosis.
Vyshkina T; Kalman B
Mult Scler; 2008 May; 14(4):433-9. PubMed ID: 18208878
[TBL] [Abstract][Full Text] [Related]
30. Characterizing the mechanisms and progression in multiple sclerosis: evidence and new hypotheses for future directions.
Crawford CL; Hardwicke PM
Arch Neurol; 2006 May; 63(5):786-7; author reply 787-8. PubMed ID: 16682555
[No Abstract] [Full Text] [Related]
31. The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.
Matesanz F; Fernández O; Milne RL; Fedetz M; Leyva L; Guerrero M; Delgado C; Lucas M; Izquierdo G; Alcina A
J Neuroimmunol; 2008 Mar; 195(1-2):146-50. PubMed ID: 18313765
[TBL] [Abstract][Full Text] [Related]
32. BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the Polish population. Gender differences.
Mirowska-Guzel D; Mach A; Gromadzka G; Czlonkowski A; Czlonkowska A
J Neuroimmunol; 2008 Jan; 193(1-2):170-2. PubMed ID: 18061279
[TBL] [Abstract][Full Text] [Related]
33. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients.
Wieczorek S; Hoffjan S; Chan A; Rey L; Harper L; Fricke H; Holle JU; Gross WL; Epplen JT; Lamprecht P
Genes Immun; 2009 Sep; 10(6):591-5. PubMed ID: 19536154
[TBL] [Abstract][Full Text] [Related]
34. Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.
Martin R
Neurodegener Dis; 2008; 5(1):23-6. PubMed ID: 18075271
[TBL] [Abstract][Full Text] [Related]
35. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
[TBL] [Abstract][Full Text] [Related]
36. EVI5 is a risk gene for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 7 receptor alpha as a potential therapeutic target in transplantation.
Racapé M; Vanhove B; Soulillou JP; Brouard S
Arch Immunol Ther Exp (Warsz); 2009; 57(4):253-61. PubMed ID: 19585222
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
Fernandes KS; Brum DG; Sandrim VC; Guerreiro CT; Barreira AA; Tanus-Santos JE
J Neuroimmunol; 2009 Sep; 214(1-2):128-31. PubMed ID: 19631393
[TBL] [Abstract][Full Text] [Related]
39. IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.
Sarial S; Shokrgozar MA; Amirzargar A; Shokri F; Radfar J; Zohrevand P; Arjang Z; Sahraian MA; Lotfi J
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):37-40. PubMed ID: 18322311
[TBL] [Abstract][Full Text] [Related]
40. IL23R: a susceptibility locus for celiac disease and multiple sclerosis?
Núñez C; Dema B; Cénit MC; Polanco I; Maluenda C; Arroyo R; de las Heras V; Bartolomé M; de la Concha EG; Urcelay E; Martínez A
Genes Immun; 2008 Jun; 9(4):289-93. PubMed ID: 18368064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
